Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Teva Takeda Deal Aimed at Boosting Efficiency, Quality: Nichi-Iko Chief
July 31, 2020
- Teva Takeda Narrowing Focus on Unique Generics, Eyes Innovative Meds: CEO
July 31, 2020
- Nichi-Iko Pulls Out from Avigan Contract Manufacturing
July 31, 2020
- 28 Products from 10-Plus Firms Recalled due to Flawed Tests at Kyowa CritiCare
July 31, 2020
- Sumitomo Dainippon Files Japan NDA for Poxel’s Diabetes Med
July 31, 2020
- Eisai Seeks Lenvima’s Label Expansion into Thymic Carcinoma
July 31, 2020
- Nichi-Iko to Acquire Teva Takeda’s Generic Business
July 30, 2020
- Healios Starts Enrolling COVID-19 Patients in ARDS Cell Therapy Program
July 30, 2020
- Life Science Institute’s Muse Cell Therapy Effective in Epidermolysis Bullosa
July 30, 2020
- Otsuka Files Japan NDA for Preventive Treatment of Migraines
July 30, 2020
- Generic APIs at Crossroads - 1: Sawai Quality Chief Says Current Biz Structure Hampers Manufacturing Repatriation
July 29, 2020
- Santen Bags Rights to Osmotica’s Droopy Eyelid Drug
July 29, 2020
- Eisai, DeNA Launch Smartphone App for Dementia Prevention
July 29, 2020
- Ibrance Now Available in Tablet Forms: Pfizer Japan
July 29, 2020
- Pfizer Japan Has Different Interpretation on Lyrica Patent Ruling
July 29, 2020
- Novartis Links Up with Ehime Pref., Ehime Univ. to Fuel Cardiovascular Disease Prevention
July 29, 2020
- Chugai’s Half-Year Earnings Surge on Actemra/Hemlibra Exports
July 28, 2020
- EU Panel Gives Thumbs-Up to Avastin Biosimilar
July 28, 2020
- Daiichi Sankyo, AstraZeneca to Collaborate for Another ADC
July 28, 2020
- Lyrica Expected to Face Generic Onslaught by Year’s End as Patent Ruled Invalid
July 28, 2020
